Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$235.00
-4.15-1.74%
Last update: Oct 16, 4:00 PM
$235.00
-4.15-1.74%
Quest Diagnostics Inc (DGX) Stock Price, Quote, News & History
DGXNYSE
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Quest Diagnostics (NYSE:DGX) through any online brokerage.
Other companies in Quest Diagnostics’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Guardant Health Inc (NASDAQ:GH) and Fresenius Medical Care AG (NYSE:FMS).
Quest Diagnostics has a consensus price target of $213.39.
The stock price for Quest Diagnostics (NYSE: DGX) is $235 last updated October 16, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Quest Diagnostics.
Quest Diagnostics does not have any upcoming earnings scheduled.
There is no upcoming split for Quest Diagnostics.
Quest Diagnostics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
